The funding round also saw the participation of TF Fund and the LYZZ Healthcare Venture Fund, according to a AlphaBio press release. The firm is looking at raising $65 million for the entire Series A financing round.
Create an account to continue reading this premium story for freeRegister
Already a Subscriber? Log in